Dry eye common in early GO

Article

According to recent data, dry eye has been found to be common in patients with early Graves Ophthalmology (GO).

According to recent data, dry eye has been found to be common in patients with early Graves Ophthalmology (GO).

Dr Vasilis Achtsidis et al., Attikon University Hospital, University of Athens, Greece, evaluated a total of 52 eyes of 26 patients with early GO and 37 control subjects. GO diagnosis was based on the European Group on Graves Orbitopathy consensus statement. The team also calculated Clinical Activity Score (CAS) and Werner-NOSPECS Score, as well as corneal sensitivity using a Cochet-Bonnet aesthesiometer.

Of the participants included in the study, 67.8% with early GO and 13.5% of healthy controls presented with ocular surface dryness. Mean Schirmer test scores were significantly lower in GO patients, compared to controls and these results correlated with CAS. Tear film break up time was lower in patients by 5.46 seconds and 5.74 seconds in the right and left eyes, respectively.

Dry eye is common in GO, despite the absence of apparent exophthalmos, and based on the results the team concluded that there was an association with CAS as well as reduced corneal sensitivity.

To read the abstract please visit the European Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.